Management of Left-Sided Pleural Effusion in Heart Failure

Initial Assessment and Management

The European Society of Cardiology recommends optimizing medical therapy with intravenous loop diuretics, such as furosemide 20-40 mg IV initially, while evaluating the need for diagnostic thoracentesis to exclude non-cardiac causes in patients with heart failure presenting with a left-sided pleural effusion 1, 2, 3
Assess volume status, orthostatic blood pressure changes, weight, and calculate body mass index to determine the degree of congestion in patients with heart failure and pleural effusion, as recommended by the American Heart Association 4
Obtain 12-lead ECG, complete blood count, comprehensive metabolic panel, cardiac troponin, thyroid-stimulating hormone, and thoracic ultrasound to evaluate patients with heart failure and pleural effusion, as suggested by the European Society of Cardiology 2
Measure natriuretic peptides, such as BNP or NT-proBNP, to support cardiac versus non-cardiac etiology, with NT-proBNP ≥1500 pg/mL strongly supporting cardiac origin, as recommended by the American College of Cardiology 2

Perform diagnostic thoracentesis if unilateral left-sided effusion, fever, leukocytosis, or pleuritic chest pain are present, as recommended by the European Respiratory Society 5, 3
Use ultrasound-guided thoracentesis to reduce complications and improve success rates, as suggested by the American Thoracic Society 3
Send pleural fluid for protein, LDH, cell count with differential, pH, glucose, cytology, Gram stain, and culture to evaluate the etiology of the pleural effusion, as recommended by the European Respiratory Society 2, 3
Apply Light's criteria to differentiate exudates from transudates, as recommended by the American Thoracic Society 3

Administer furosemide 20-40 mg IV as initial dose for patients not on oral diuretics, and consider combination therapy with thiazide-type diuretic or spironolactone for refractory cases, as recommended by the European Society of Cardiology 1
Consider IV vasodilators for symptomatic relief in patients with systolic blood pressure >90 mmHg without symptomatic hypotension, as suggested by the American College of Cardiology 1

Consider CPAP or bi-level positive pressure ventilation for patients with respiratory distress to reduce work of breathing and improve oxygenation, as recommended by the European Society of Cardiology 1
Increase FiO₂ up to 100% if necessary according to SpO₂, but avoid hyperoxia, as suggested by the American Thoracic Society 1

Obtain chest radiography to confirm effusion size and assess for pulmonary congestion, and perform two-dimensional echocardiography with Doppler during initial evaluation to assess left ventricular ejection fraction, as recommended by the American Heart Association 4
Use serial chest X-rays to monitor response to diuretic therapy and ensure resolution of effusion, as suggested by the European Society of Cardiology 3
Typical pleural effusions in uncomplicated heart failure should show improvement with medical therapy within 5 days, as recommended by the European Respiratory Society 5

For symptomatic effusions refractory to maximal tolerated diuretic therapy, consider repeat ultrasound-guided thoracentesis for symptomatic relief, as recommended by the European Respiratory Society 6
Consider indwelling pleural catheter only if frequent thoracenteses are required, though this is associated with higher adverse event rates compared to repeat thoracentesis, as suggested by the European Respiratory Society 6
Talc pleurodesis may be considered but is associated with longer hospital stay, higher readmission rates, and greater morbidity compared to IPC alone, as recommended by the European Respiratory Society 5